Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia (NYSE:PHR) has launched VoiceAI, an innovative AI-powered phone solution designed specifically for healthcare organizations. This new technology integrates with Phreesia's existing patient activation platform to manage high call volumes and streamline patient interactions using natural language processing.
The system features intelligent triage, reliable AI responses based on clinical rules, parallel call handling capacity, and integrated documentation capabilities. VoiceAI handles common healthcare requests including scheduling, prescription refills, and clinical questions 24/7. Early implementation at Urology Associates of Mobile has already demonstrated success, reducing call abandonment rates to zero.
In 2024, Phreesia facilitated approximately 170 million patient visits, representing 1 in 7 healthcare visits across the United States.
Phreesia (NYSE:PHR) and Sesame Workshop have announced a significant 5-year collaboration aimed at improving children's health education and engagement. The partnership will leverage Sesame Street's beloved characters to deliver health-related educational content through Phreesia's digital intake platform, reaching families during medical visits.
Starting October 2025, the initiative will target caregivers of children aged 0-5, providing information about preventive care, vaccinations, routine check-ups, and emotional wellbeing. The collaboration combines Phreesia's reach of one in seven patient visits across the U.S. with Sesame Workshop's 55-year legacy in educational excellence.
Phreesia (NYSE:PHR), a leading patient intake and activation solutions provider, has been recognized on the 2025 Capterra Shortlist in two categories: Patient Engagement and Medical Scheduling. The company maintains a strong 4.3 out of 5 rating on Capterra, based on verified user reviews.
Founded in 2005, Phreesia has demonstrated significant market penetration, facilitating approximately 170 million patient visits in 2024, representing 1 in 7 healthcare visits across the United States. The company's digital solutions portfolio includes patient intake, outreach, education, and other healthcare management tools.
Phreesia (NYSE: PHR), a patient activation solutions provider, has scheduled its fiscal second quarter 2026 financial results announcement for September 4, 2025, after market close. The company will host a conference call at 5:00 PM Eastern Time on the same day to discuss the results.
Founded in 2005, Phreesia serves as a significant player in healthcare technology, facilitating approximately 170 million patient visits in 2024 - representing 1 in 7 healthcare visits across the United States. The company specializes in providing digital solutions for patient intake, outreach, and education to enhance patient experience and healthcare outcomes.
Phreesia (NYSE:PHR) and the COPD Foundation have released a comprehensive study revealing significant gaps in COPD patient care and communication. The research, funded by Verona Pharma, surveyed 1,615 COPD patients in January 2025 through Phreesia's platform.
Key findings show that 43% of patients experience symptoms at least 24 days per month, with 25% reporting daily symptoms. The study highlighted concerning statistics: only 45% of patients have detailed symptom discussions with providers, 20% don't use maintenance medications, and over one-third have limited COPD understanding. The impact is particularly pronounced among Black patients and those aged 45-64 years.
The research emphasizes the critical need for improved patient-provider communication and targeted interventions to enhance COPD care management and patient outcomes.
Phreesia (NYSE:PHR), a leading patient intake and activation solutions provider, has been recognized as the 2025 Top-Rated Vendor for Patient Registration and Intake Solutions by Black Book Research. The recognition is based on surveys from over 11,500 healthcare professionals.
The company's selection highlights significant industry trends, with 89% of respondents reporting that front-end process issues directly impact cash flow and claims, while 77% of providers increased investments in automation tools for patient access, up from 63% in 2023. Phreesia facilitated approximately 170 million patient visits in 2024, representing 1 in 7 visits across the U.S.
Summary not available.
Phreesia (NYSE: PHR) has updated the timing of its fiscal first quarter 2026 financial results release to before market trading on Wednesday, May 28, 2025, instead of after market close as previously announced. The company will host a conference call at 8:30 AM Eastern Time on the same day to discuss the results.
Phreesia, founded in 2005, is a healthcare technology company specializing in patient activation solutions. In 2024, the company facilitated approximately 170 million patient visits, representing 1 in 7 healthcare visits across the United States. The company provides digital solutions for patient intake, outreach, and education to enhance patient experience and healthcare outcomes.
Phreesia (NYSE: PHR) has scheduled the release of its fiscal first quarter 2026 financial results for Wednesday, May 28, 2025, after market close. The company will host a conference call at 5PM Eastern Time on the same day, with dial-in numbers (800) 715-9871 for domestic and (646) 307-1963 for international participants.
Key Details:
- Conference code: 7404611
- Results will be posted on ir.phreesia.com
- Call replay available for approximately 90 days
Company Overview: Founded in 2005, Phreesia is a leader in patient activation solutions for healthcare providers and life sciences companies. In 2024, the platform facilitated approximately 170 million patient visits, representing 1 in 7 healthcare visits across the United States. The company specializes in digital solutions for patient intake, outreach, and education to enhance patient experience and healthcare outcomes.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
